Moderna ^Investor

Moderna Therapeutics is a biotechnology company that specializes in the development of messenger RNA (mRNA) therapeutics. Their innovative technology allows for the production of human proteins and antibodies inside patient cells, with a focus on disease areas such as genetic disorders, hemophilia, and oncology. Moderna has achieved significant milestones, including receiving positive opinions for their RSV vaccine and entering joint agreements with Mitsubishi Tanabe Pharma Corporation to promote their mRNA respiratory vaccine portfolio in Japan. Their mission is to deliver the greatest possible impact to people through mRNA medicines, and they continue to make strides in revolutionizing the world of medicine.